ERBB2 and invasive breast carcinoma: Such association was seen in studies that recruited exclusively TNBC and/or HER2-enriched cases (n = 4) [30,31,32,35], as well as in cohorts that included invasive breast cancer of non-specified, non-TNBC subtypes (n = 3) [33,34,41].